Antiaggresive and anxiolytic effects of gepirone in mice, and their attenuation by WAY 100635

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 3, 1999, Pages 499-509

  Mendoza, Diana Lopez ^a   Bravo, Helena Aguilar ^a   Swanson, Heidi H ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Anxiety; Gepirone; Mice; Territorial aggression; WAY 100635

Indexed keywords

GEPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST;

AGGRESSION; ANIMAL MODEL; ARTICLE; BEHAVIOR; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

AGGRESSION; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED BALB C; PIPERAZINES; PYRIDINES; PYRIMIDINES; RESTRAINT, PHYSICAL; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0042395224     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00171-3     Document Type: Article

References (57)

1. 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels. (S)-WAY 100135, but not WAY 100635, has partial agonists properties Eur. J. Pharmacol. 304:1996;15-21.
2. Bell R., Donaldson C., Gracey D. Differential effects of CGS 12066B and CP-94,253 on murine social and agonistic behaviour. Pharmacol. Biochem. Behav. 52:1995;7-16.
3. Bell R., Mitchell P.J., Hobson H. Effects of the 5-HT1A antagonist (+)-WAY-100135 on murine social and agonistic behavior. Pharmacol. Biochem. Behav. 54:1996;159-167.
4. 1A receptors. J. Neurochem. 66:1996;2546-2555.
5. 1A receptor agonist and antagonist on the 5-hydroxytryptamine release in the central nucleus of the amygdala. A microdialysis study with flesinoxan and WAY 100635 Naunyn Schmiedebergs Arch. Pharmacol. 355:1997;347-353.
6. 1A receptor antagonism on plus-maze behaviour in mice, II. WAY 100635, SDZ 216-525 and NAN-190. Pharmacol. Biochem. Behav. 58:1997;593-603.
7. Cao B.J., Rodgers R.J. Anxiolytic-like profile of p-MPPI, a novel 5-HT-1A receptor antagonist in the murine elevated plus-maze. Psychopharmacology (Berlin). 129:1997;365-371.
8. 2 receptors in mice. Pol. J. Pharmacol. Pharm. 44:1992;251-260.
9. Clarke R.W., Harris J., Houghton A.K. Spinal 5-HT-receptors and tonic modulation of transmission through a withdrawal reflex pathway in the decerebrated rabbit. Br. J. Pharmacol. 119:1996;1167-1176.
10. 1A antagonist, WAY 100635. Psychopharmacology (Berlin). 132:1997;35-43.
11. Corradetti R., LePoul E., Laaris N., Hamon M., Lanfumey L. Electrophysiological effects of N-(-2-(4-(2-methoxypenyl)-1-piperazinyl)ethyl)-N-(2-pyridiny1) ciclohexane carboxamine (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro. J. Pharmacol. Exp. Ther. 278:1996;679-688.
12. 1A receptor. A new effective principle in psychopharmacologic therapy? Fortschr. Neurol. Psychiatr. 64:1996;460-472.
13. 1D autoreceptors. Br. J. Pharmacol. 114:1995;1107-1109.
14. DeAlmeida, R. M. M.; Giovenardi, M.; Charchat, H.; Lucion, A. B.: 8-OH-DPAT in different areas of brain have either anxiogenic or anxiolytic effects in female rats. Second Ethopharmacology Conference, Sopron; 1996 (published in Neurobiology 5:282; 1997).
15. DeAlmeida, R. M. M.; Giovenardi, M.; Charchat, H.; Lucion, A. B.: 8-OH-DPAT in different areas of brain have either anxiogenic or anxiolytic effects in female rats. Second Ethopharmacology Conference, Sopron; 1996 (published in Neurobiology 5:282; 1997).
16. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus maze. Pharmacol. Biochem. Behav. 54:1996;31-40.
17. 1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 16:1996;4810-4815.
18. 1A receptor antagonist. Behav. Brain Res. 73:1996;337-353.
19. 1A antagonist, increases serotonergic neuronal activity in behaving cats. Comparison with (S)-WAY 100135 J. Pharmacol. Exp. Ther. 278:1996;752-762.
20. 1A receptor antagonist, WAY 100635. Eur. J. Pharmacol. 281:1995;81-88.
21. 1A receptors in rat brain membranes. Eur. J. Pharmacol. 288:1995;173-186.
22. Grant E.C., Mackintosh J.H. A description of the social postures of some common laboratory rodents. Behaviour. 21:1963;246-259.
23. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Risk assessment behaviour. Evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test Pharmacol. Biochem. Behav. 57:1997;817-827.
24. Halasz, J.; Haller, J.; Makara, G. B.: The effect of social experience on the behavioral effectiveness of anxiolytic drugs. Second Ethopharmacology Conference, Sopron; 1996 (published in Neurobiology 5:292; 1997.).
25. Halasz, J.; Haller, J.; Makara, G. B.: The effect of social experience on the behavioral effectiveness of anxiolytic drugs. Second Ethopharmacology Conference, Sopron; 1996 (published in Neurobiology 5:292; 1997.).
26. 1A autoreceptors and alfa 1-adrenoceptors in the inhibition of 5-HT release - I. BMY7378 and prazosin. Neuropharmacology. 34:1995;615-620.
27. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
28. 1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacol. Biochem. Behav. 29:1988;711-715.
29. Krsiak M. Ethopharmacology. A historical perspective Neurosci. Biobehav. Rev. 15:1991;439-445.
30. 3H]WAY 100635 in the mouse. Eur. J. Pharmacol. 271:1994;505-514.
31. Lopez Mendoza D., Aguilar Bravo H., Swanson H.H. Combined effects of Gepirone and (+) WAY 100135 on territorial aggression in mice. Pharmacol. Biochem. Behav. 61:1998;1-8.
32. 1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br. J. Pharmacol. 107:1992;15-21.
33. Mendlin A., Martin F.J., Rueter L.E., Jacobs B.L. Neuronal release of serotonin in the cerebellum of behaving rats. An in vivo microdialysis study J. Neurochem. 67:1996;617-622.
34. 1A receptors. II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties J. Pharmacol. Exp. Ther. 282:1997;148-161.
35. 1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing. Br. J. Pharmacol. 117:1996;750-756.
36. Patel S., Hutson P.H. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-HT metabolism in the mouse. Eur J. Pharmacol. 317:1996;197-204.
37. Pecknold J.C., Luthe L., Scott-Fleury M.H., Jenkins S. Gepirone and the treatment of panic disorder. An open study J. Clin. Psychopharmacol. 13:1993;145-149.
38. 1B receptor knock out - Behavioral consequences. Behav. Brain Res. 73:1996;305-312.
39. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology (Berlin). 125:1996;89-91.
40. Rickels K., Schweizer E., DeMartinis N., Mandos L., Mercer C. Gepirone and diazepam in generalized anxiety disorder. A placebo controlled trial J. Clin. Psychopharmacol. 17:1997;272-277.
41. Rodgers R.J. Animal models of "anxiety" Where next? Behav. Pharmacol. 8:1997;477-496.
42. 3 antagonists and benzodiazepines. Their comparative behavioural pharmacology:1991;195-231 John Wiley & Sons, London.
43. Rodgers R.J., Cole J.C., Cobain P., Doran P.J., Eells J.R., Wallis P. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse-elevated plus-maze. Profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP Behav. Pharmacol. 3:1992;621-634.
44. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci. Biobehav. Rev. 21:1997;801-810.
45. 1B receptors and beta-adrenoceptors. Eur. J. Pharmacol. 297:1996;1-8.
46. 1A agonist (tandospirone) Nihon Shinkei Seishin Yakurigaku Zasshi. 17:1997;53-59.
47. 1A agonists. J. Pharmacol. Exp. Ther. 270:1994;198-208.
48. 1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release - II. NAN-190 and SDZ 216-525. Neuropharmacology. 35:1996;735-741.
49. Simon, N. G.: Testosterone-serotonin interactions in aggression. Second Ethopharmacology Conference. Sopron, 1996 (published in Neurobiology 5:322; 1997).
50. Simon, N. G.: Testosterone-serotonin interactions in aggression. Second Ethopharmacology Conference. Sopron, 1996 (published in Neurobiology 5:322; 1997).
51. 1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat. Psychopharmacology (Berlin). 128:1996;293-303.
52. Stefanski R., Palejko W., Kostowski W., Plaznik A. The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety. Neuropharmacology. 31:1992;1251-1258.
53. Tornatzky W., Miczek K.A. Alcohol, anxiolytics and social stress in rats. Psychopharmacology (Berlin). 121:1995;135-144.
54. Vale A.L., Montgomery A.M. Social interaction. Responses to chlordiazepoxide and the loss of isolation-reared effects with paired-housing Psychopharmacology (Berlin). 133:1997;127-132.
55. Valzelli L. Aggression and violence. A biological essay of the distinction Valzelli L., Morgese I. Aggression and violence. A psychobiological approach:1981;39-60 Ediz. St. Vincent, Milan.
56. Vivian J.A., Miczek K.A. Diazepam and Gepirone selectively attenuate either 20-32 or 32-64 kHz ultrasonic vocalizations during aggressive encounters. Psychopharmacology (Berlin). 112:1993;66-73.
57. 1A receptors and relationship to anxiolytic effect Eur. J. Pharmacol. 323:1997;59-68.